Skip to content
MARKETS / NASDAQ / OFIX
NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP

Orthofix Medical Inc. OFIX

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$822.3M
▲ 2.9% YoY
$-92.2M
$-1.3M
In brief

What this company does

Orthofix offers a portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. The company is headquartered in Lewisville, Texas. As of December 31, 2025, the company had 1,605 employees worldwide, of whom 1,222 were employed in the U.S. and 383 at other non-U.S. locations. Orthofix operates its business through two reporting segments, Global Spine and Global Limb Reconstruction, which accounted for 84% and 16% of its total net sales in 2025, respectively. Within the Global Spine segment, the company provides implantable medical devices, biologics, enabling technologies and other regenerative solutions for patients with diseases and traumas of the spine. The company was founded in Verona, Italy in 1980 and formally incorporated in 1987 in Curaçao as "Orthofix International N.V." In 2018, it changed its jurisdiction of organization from Curaçao to the State of Delaware and changed its name to "Orthofix Medical Inc."

Written from the business description in Orthofix Medical Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.

Growth
USD 822.3M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 822.3 · Net income -92.2
400M800M-80M200920112013201520172019202120232025
Compound annual growth
+21.3%
+15.1%
+7.6%
+3.9%
+6.6%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.1% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−11 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -9.9% · Net -11.2%
5%10%15%-10%-20%200920112013201520172019202120232025
ROE
FY2025 · ROE -19.3%
5%10%15%-10%-20%-30%200920112013201520172019202120232025

Each USD of equity lost 19 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -1.3
20M40M-40M-80M200920112013201520172019202120232025
Net buybacks $M Dividends $M
FY2016 · Dividends — · Net buybacks 43.7
20M40M201320152016

Total assetsUSD 850.6M
EquityUSD 450.0M
CashUSD 82.0M
Gross debtUSD 157.4M
Net debtUSD 75.4M
Current ratio2.45×

Net debt stands at 17% of equity.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.80.80.70.50.50.40.50.50.40.40.40.40.40.40.40.50.5
Operating income $B−0.1−0.1−0.1−0.0−0.0−0.0−0.00.00.00.00.00.0−0.00.10.00.10.1
EBITDA $B−0.0−0.0−0.10.00.00.00.00.00.10.00.00.00.00.10.00.10.1
Income tax $B0.00.00.00.00.0−0.00.00.00.00.00.00.00.00.00.0−0.00.0
Net income $B−0.1−0.1−0.2−0.0−0.00.0−0.00.00.00.0−0.0−0.0−0.00.0−0.00.00.0
Free cash flow $B−0.0−0.0−0.1−0.00.00.10.00.00.00.00.00.00.0−0.00.00.00.0
EPS, diluted $−2.33−3.30−4.12−0.98−1.950.13−1.510.720.340.17−0.15−0.46−1.542.21−0.972.471.42
Dividend / sh $·················
Payout %·················
ROE %−19.3−22.9−32.4−5.9−11.10.7−8.64.42.21.1−1.0−2.9−8.813.5−6.116.410.2
Shares out B0.040.040.040.020.020.020.020.020.020.020.020.020.020.020.020.02·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 83 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivitySurgical & Medical Instruments & Apparatus
Listed onNASDAQ
Incorporated innot stated in the filings
Fiscal year endsDecember 23
Data on record since2009

Share this section

Download image